Literature DB >> 15472537

Chromoendoscopy: an evolving standard in surveillance for ulcerative colitis.

R Kiesslich1, M F Neurath.   

Abstract

Entities:  

Year:  2004        PMID： 15472537     DOI： 10.1097/00054725-200409000-00031

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN： 1078-0998            Impact factor:   5.325


× No keyword cloud information.
  5 in total

Review 1.  [Early diagnosis of colorectal tumors].

Authors:  C Lamberti; T Sauerbruch
Journal:  Internist (Berl)       Date:  2005-04       Impact factor: 0.743

2.  Genomic biomarkers to improve ulcerative colitis neoplasia surveillance.

Authors:  Mary P Bronner; Jacintha N O'Sullivan; Peter S Rabinovitch; David A Crispin; Lu Chen; Mary J Emond; Cyrus E Rubin; Teresa A Brentnall
Journal:  Am J Pathol       Date:  2008-11-06       Impact factor: 4.307

3.  Array-based comparative genomic hybridization in ulcerative colitis neoplasia: single non-dysplastic biopsies distinguish progressors from non-progressors.

Authors:  Mary P Bronner; Marek Skacel; David A Crispin; Peter D Hoff; Mary J Emond; Lisa A Lai; Raymond R Tubbs; Jacintha N O'Sullivan; Peter S Rabinovitch; Teresa A Brentnall
Journal:  Mod Pathol       Date:  2010-08-27       Impact factor: 7.842

4.  Chromoendoscopy detects more adenomas than colonoscopy using intensive inspection without dye spraying.

Authors:  Elena M Stoffel; D Kim Turgeon; David H Stockwell; Daniel P Normolle; Missy K Tuck; Norman E Marcon; John A Baron; Robert S Bresalier; Nadir Arber; Mack T Ruffin; Sapna Syngal; Dean E Brenner
Journal:  Cancer Prev Res (Phila)       Date:  2008-12

Review 5.  Advanced endoscopic imaging for surveillance for dysplasia and colorectal cancer in inflammatory bowel disease: could the pathologist be further helped?

Authors:  Emanuele Sinagra; Giovanni Tomasello; Dario Raimondo; Andreas Sturm; Marco Giunta; Marco Messina; Giuseppe Damiano; Vincenzo D Palumbo; Gabriele Spinelli; Francesca Rossi; Tiziana Facella; Salvatore Marasà; Mario Cottone; Attilio I Lo Monte
Journal:  Saudi J Gastroenterol       Date:  2014 Jan-Feb       Impact factor: 2.485
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.